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Risk assessment has become an important tool to assess an individual’s future risk for 
cardiovascular disease. Recently, the American College of Cardiology/American Heart 
Association (ACC/AHA) released a report that presented updated risk equations, the Pooled 
Cohort Risk Equations, for cardiovascular disease.1 Race and ethnicity-specific estimates 
were novel to the new risk equations. Because changes over time in predicted cardiovascular 
risk using these new risk equations have not been examined, our objectives were to (1) 
examine the trend in predicted 10-year cardiovascular risk using the new ACC/AHA Pooled 
Cohort Risk Equations and (2) estimate the potential for risk reduction by optimizing levels 
of cardiovascular risk factors.
Methods
We used data from seven 2-year cycles of the National Health and Nutrition Examination 
Survey (1999-2000 to 2011-2012) that includes nationally representative samples of the US 
population selected with a complex multistage sampling design.2 Response rates for the 
interview and examination stages all exceeded 70%. The surveys were approved by the 
National Center for Health Statistics Research Ethics Review Board.
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We used the Pooled Cohort Risk Equations to calculate predicted 10-year cardiovascular 
risk1 and limited the analyses to men and nonpregnant women who were aged 40 to 79 years 
and free of self-reported congestive heart failure, coronary heart disease, angina, myocardial 
infarction, or stroke. Tests for trend were calculated by using orthogonal linear contrasts. 
Racial- or ethnic-specific estimates were limited to the 3 major racial or ethnic groups (ie, 
Mexican American, non-Hispanic white, and non-Hispanic black). To account for the 
complex sampling design of the surveys, we conducted the analyses with SUDAAN 
statistical software (RTI International).
Results
Of the 5 modifiable cardiovascular risk factors, significant improvements occurred for total 
cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, and smoking status 
(Table 1). The prevalence of diabetes increased progressively.
Overall, risk of 20% or greater declined from 13.0% to 9.4% (P value for trend, .008). Risk 
of 20% or greater decreased significantly among women (P value for trend, <.001), non-
Hispanic whites (P value for trend, .02), non-Hispanic white women (P value for trend, .
001), and non-Hispanic black women (P value for trend, .03). During each 2-year cycle, 
predicted 10-year cardiovascular risk of 20% or greater was higher among men compared 
with women and among non-Hispanic black women compared with non-Hispanic white 
women.
Using data from 2011-2012, we examined the potential impact of aligning modifiable risk 
factors levels with optimal values on predicted 10-year cardiovascular risk. The reduction of 
systolic blood pressure to lower than 120 mm Hg yielded the largest drop in mean predicted 
risk, followed by the elimination of diabetes, and elimination of smoking (Table 2). When 
all 5 cardiovascular risk factors were simultaneously optimized, mean predicted risk 
declined by 3.3% overall, 6.4% among non-Hispanic black men, and 4.5% among non-
Hispanic black women.
Discussion
Our results show that predicted 10-year cardiovascular risk among women has improved 
substantially compared with men; predicted risk was higher among non-Hispanic black 
women than among non-Hispanic white and Mexican American women; and predicted risk 
lower than 7.5% declined significantly among non-Hispanic black men. Also, improvements 
in risk factors levels, led by systolic blood pressure, can produce substantial reductions in 
future cardiovascular disease. Interventions aimed at improving the modifiable risk factors 
other than total cholesterol level could help to narrow the gender gap in predicted risk, and 
improving systolic blood pressure and concentrations of hemoglobin A1c could help to 
narrow the racial disparity.
The limited evidence about the validity of the Pooled Cohort Risk Equations poses one 
limitation.3 Furthermore, we were unable to exclude participants who underwent 
cardiovascular procedures such as percutaneous coronary interventions.
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Sex and racial disparities in cardiovascular risk continue to exist, and the risk factors fueling 
these disparities will require redress. The enormous progress in reducing cardiovascular 
disease mortality realized since the 1960s represent public health and health care 
improvement successes, yet more progress in reducing the remaining colossal burden of 
cardiovascular disease in the United States awaits.
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Table 1
Cardiovascular Risk Factors and Unadjusted Distribution of Predicted 10-Year Risk for Cardiovascular 



















Age, mean (SE), y
 Total 54.3 (0.4) 53.5 (0.2) 53.8 (0.3) 54.1 (0.6) 54.4 (0.3) 54.8 (0.2) 55.1 (0.3) .002
 NHW 54.8 (0.5) 54.0 (0.3) 54.2 (0.4) 54.7 (0.7) 54.9 (0.4) 55.5 (0.3) 55.8 (0.3) .002
 NHB 52.5 (0.4) 52.0 (0.7) 52.9 (0.6) 53.0 (0.5) 53.5 (0.4) 53.9 (0.5) 54.1 (0.5) .001
 MA 51.2 (0.5) 50.6 (0.9) 51.2 (0.8) 51.3 (0.5) 51.8 (0.8) 51.8 (0.5) 50.6 (0.7) .75
Current smoker, % (SE)
 Total 20.6 (1.6) 20.5 (1.1) 22.1 (1.2) 22.2 (1.6) 19.8 (1.7) 17.1 (1.1) 19.1 (0.9) .045
 NHW 19.5 (1.8) 18.8 (1.5) 20.9 (1.2) 21.4 (2.2) 19.5 (2.4) 15.7 (1.4) 19.3 (1.1) .31
 NHB 31.3 (3.3) 29.7 (2.7) 29.3 (2.9) 27.0 (2.5) 25.8 (2.2) 28.7 (4.0) 22.0 (2.6) .04
 MA 20.8 (2.6) 21.5 (1.5) 20.6 (2.4) 19.0 (1.8) 16.9 (2.5) 17.8 (1.9) 18.5 (3.1) .19
TC, mean (SE), mg/dL
 Total 214.3 (1.9) 211.7 (1.5) 209.8 (1.5) 207.1 (1.1) 205.2 (1.3) 205.9 (1.7) 205.0 (1.3) <.001
 NHW 216.6 (2.4) 210.8 (1.4) 211.0 (1.6) 207.6 (1.4) 205.0 (1.6) 207.2 (2.0) 206.6 (1.6) <.001
 NHB 204.2 (2.6) 208.6 (3.1) 203.9 (2.1) 197.8 (2.1) 200.1 (1.8) 199.7 (1.6) 198.3 (1.6) .001
 MA 211.9 (1.2) 209.2 (3.5) 208.5 (2.8) 208.1 (1.7) 208.2 (1.6) 204.2 (1.6) 200.3 (2.9) .001
HDL-C, mean (SE), mg/dL
 Total 52.2 (0.9) 52.9 (0.5) 54.6 (0.5) 55.5 (0.4) 52.9 (0.6) 54.9 (0.5) 54.1 (0.7) .04
 NHW 52.8 (1.1) 53.1 (0.7) 54.7 (0.5) 55.6 (0.5) 52.8 (0.7) 55.3 (0.7) 54.8 (0.9) .08
 NHB 53.7 (0.8) 56.5 (1.0) 57.6 (1.0) 59.2 (0.8) 58.3 (0.9) 57.4 (0.9) 56.2 (0.6) .02
 MA 48.2 (0.8) 48.9 (0.5) 50.2 (0.6) 50.0 (1.0) 49.9 (0.8) 50.1 (1.0) 49.2 (1.1) .30
SBP, mean (SE), mm Hg
 Total 127.3 (0.9) 126.2 (0.5) 126.1 (0.7) 125.0 (0.6) 123.6 (0.5) 122.6 (0.6) 123.8 (0.7) <.001
 NHW 126.3 (1.1) 125.7 (0.6) 125.4 (0.8) 124.6 (0.6) 123.3 (0.6) 121.8 (0.7) 123.2 (0.8) <.001
 NHB 132.9 (1.0) 132.2 (1.0) 130.7 (1.5) 130.6 (0.7) 126.9 (1.7) 128.5 (1.2) 128.1 (1.0) <.001
 MA 127.7 (1.0) 125.5 (0.6) 125.8 (1.4) 123.9 (0.9) 123.9 (1.3) 125.1 (0.8) 122.7 (1.1) .001
Diabetes, % (SE)
b
 Total 9.9 (1.2) 10.1 (0.8) 10.9 (0.8) 10.5 (1.0) 12.6 (0.9) 12.6 (1.0) 13.5 (0.7) .001
 NHW 7.5 (1.3) 7.8 (0.8) 9.5 (1.1) 8.4 (1.1) 10.0 (1.4) 9.8 (0.8) 10.6 (0.9) .02
 NHB 17.7 (1.8) 15.7 (1.8) 14.6 (1.4) 17.8 (2.5) 23.7 (1.1) 20.2 (1.8) 24.1 (2.3) .001
 MA 16.5 (2.2) 17.7 (1.1) 18.7 (1.9) 18.9 (1.1) 20.5 (2.2) 21.4 (2.3) 22.6 (3.2) .04




   Total 63.1 (1.9) 66.1 (1.4) 65.7 (0.9) 66.5 (2.1) 67.1 (1.3) 66.5 (0.9) 63.9 (1.1) .54































   NHW 63.1 (2.6) 66.9 (1.7) 66.1 (1.2) 67.1 (2.5) 68.0 (1.8) 66.9 (0.9) 64.6 (1.5) .53
   NHB 54.1 (2.6) 57.2 (2.2) 57.4 (2.2) 55.7 (2.8) 57.4 (2.8) 54.0 (2.5) 51.3 (2.2) .25
   MA 69.2 (2.3) 73.4 (3.7) 73.4 (3.1) 72.4 (2.1) 69.9 (3.0) 70.6 (3.3) 72.1 (4.5) .99
  Men
   Total 52.1 (2.5) 58.1 (1.9) 54.0 (1.9) 57.3 (2.9) 56.3 (1.8) 54.9 (1.2) 48.7 (2.4) .23
   NHW 52.2 (3.4) 59.5 (2.2) 55.1 (2.4) 59.1 (3.6) 57.6 (2.4) 54.4 (1.3) 49.1 (3.2) .28
   NHB 47.8 (3.5) 46.7 (4.5) 46.7 (3.1) 42.4 (3.5) 48.6 (4.8) 44.0 (2.4) 32.0 (3.0) .006
   MA 58.2 (3.5) 66.5 (4.5) 65.3 (3.9) 65.2 (3.0) 59.9 (4.0) 61.1 (4.5) 57.4 (7.5) .51
  Women
   Total 72.6 (1.8) 74.0 (1.4) 76.5 (1.4) 74.7 (2.2) 76.7 (1.5) 76.9 (0.9) 77.6 (1.1) .005
   NHW 72.9 (2.3) 74.3 (1.8) 76.5 (1.3) 74.5 (2.5) 77.4 (2.0) 78.3 (1.0) 78.6 (1.4) .008
   NHB 59.2 (4.0) 67.2 (2.8) 66.2 (3.7) 66.9 (2.4) 64.2 (2.2) 62.0 (2.7) 66.6 (2.0) .55
   MA 79.4 (2.4) 80.2 (3.9) 82.5 (2.9) 79.8 (2.0) 79.5 (3.8) 81.1 (2.2) 88.8 (2.7) .07
 7.5% to <20%
  Total
   Total 23.9 (1.7) 22.8 (0.7) 23.6 (0.8) 23.4 (1.4) 22.3 (1.0) 23.4 (0.5) 26.8 (1.2) .20
   NHW 23.7 (2.2) 22.4 (1.0) 23.7 (1.0) 22.8 (1.7) 21.3 (1.4) 23.6 (0.7) 26.3 (1.5) .37
   NHB 29.6 (2.1) 27.6 (1.8) 28.3 (2.1) 29.8 (2.1) 28.8 (2.2) 31.6 (1.6) 36.1 (1.4) .004
   MA 21.6 (1.7) 18.3 (2.7) 15.8 (1.4) 18.8 (1.9) 20.7 (1.7) 18.6 (1.9) 19.7 (4.2) >.99
  Men
   Total 30.7 (2.1) 28.0 (1.3) 31.6 (1.6) 30.3 (2.5) 29.4 (1.4) 32.8 (0.8) 36.8 (2.7) .02
   NHW 30.3 (2.8) 27.3 (1.7) 31.0 (1.9) 28.7 (3.1) 27.2 (2.1) 33.8 (1.1) 36.0 (3.4) .07
   NHB 35.8 (2.1) 37.2 (2.6) 38.1 (2.0) 41.0 (3.6) 38.2 (4.5) 40.9 (2.2) 50.7 (2.4) <.001
   MA 29.8 (2.2) 22.1 (3.4) 21.0 (2.1) 24.9 (2.6) 27.5 (2.7) 23.5 (2.1) 30.2 (6.2) .63
  Women
   Total 18.0 (1.7) 17.7 (1.3) 16.2 (1.2) 17.1 (1.5) 16.0 (1.3) 15.0 (0.8) 17.7 (0.9) .33
   NHW 17.8 (2.0) 17.5 (1.8) 16.9 (1.2) 17.5 (1.8) 15.9 (1.9) 14.3 (1.0) 17.6 (1.2) .34
   NHB 24.6 (3.4) 18.6 (3.1) 20.1 (3.2) 20.3 (1.7) 21.6 (1.4) 24.3 (1.9) 24.5 (1.6) .36
   MA 14.0 (2.4) 14.5 (2.9) 10.0 (1.7) 12.5 (1.6) 14.2 (2.6) 13.1 (2.2) 7.9 (2.4) .19
 ≥20%
  Total
   Total 13.0 (1.1) 11.1 (0.9) 10.7 (0.5) 10.2 (0.9) 10.6 (0.6) 10.1 (0.6) 9.4 (0.9) .008
   NHW 13.2 (1.3) 10.7 (1.0) 10.2 (0.6) 10.0 (1.0) 10.7 (0.7) 9.5 (0.6) 9.1 (1.2) .02
   NHB 16.3 (2.0) 15.1 (2.0) 14.4 (1.8) 14.5 (2.3) 13.8 (1.2) 14.3 (1.6) 12.6 (1.5) .17
   MA 9.2 (1.3) 8.3 (1.5) 10.8 (2.2) 8.8 (1.3) 9.4 (1.9) 10.8 (1.8) 8.1 (1.4) .96
  Men
   Total 17.1 (1.5) 13.9 (1.5) 14.4 (0.9) 12.4 (1.0) 14.3 (1.0) 12.3 (0.9) 14.5 (1.5) .13
   NHW 17.5 (1.7) 13.3 (1.5) 13.9 (1.1) 12.2 (1.2) 15.2 (1.1) 11.7 (1.0) 14.9 (1.9) .26
   NHB 16.4 (3.5) 16.1 (3.0) 15.1 (2.5) 16.6 (3.3) 13.3 (1.6) 15.1 (2.6) 17.3 (2.6) .95































   MA 12.1 (1.9) 11.4 (2.3) 13.7 (3.1) 9.9 (2.2) 12.6 (3.1) 15.4 (3.0) 12.4 (3.1) .57
  Women
   Total 9.4 (0.9) 8.3 (0.8) 7.4 (1.0) 8.2 (0.9) 7.3 (0.7) 8.1 (0.4) 4.7 (0.5) <.001
   NHW 9.3 (1.3) 8.2 (1.1) 6.7 (1.0) 8.0 (1.0) 6.7 (0.9) 7.5 (0.5) 3.8 (0.7) .001
   NHB 16.2 (2.0) 14.2 (2.4) 13.7 (2.8) 12.8 (2.0) 14.2 (1.8) 13.7 (1.7) 8.9 (1.3) .03
   MA 6.6 (0.9) 5.3 (1.7) 7.5 (1.5) 7.6 (1.0) 6.4 (1.4) 5.8 (1.4) 3.3 (1.3) .15
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; MA, Mexican American; NHB, non-
Hispanic black; NHW, non-Hispanic white; SBP, systolic blood pressure; TC, total cholesterol.
SI conversion factor: To convert cholesterol to millimoles per liter, multiply by 0.0259.
a
National Health and Nutrition Examination Survey 1999-2000 to 2011-2012.
b
Participants who responded affirmatively to the question “Have you ever been told by a doctor or health professional you have diabetes or sugar 
diabetes?” or had a concentration of hemoglobin A1c level of 6.5% or greater were defined as having diabetes.
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Table 2
Absolute Change in Mean Predicted 10-Year Cardiovascular Disease (CVD) Risk Using the Pooled Cohort 
Risk Equations Based on Applying Optimal Levels for 5 CVD Risk Factors Among US Adults Aged 40 to 79 
Years Without Self-reported CVD
a
Variable
Absolute Change in Mean Predicted 10-y CVD Risk, % (95% CI)
Eliminate























































































































































Abbreviations: HDL-C, high-density lipoprotein cholesterol; MA, Mexican American; NHB, non-Hispanic black; NHW, non-Hispanic white; SBP, 
systolic blood pressure; TC, total cholesterol.
SI conversion factor: To convert cholesterol to millimoles per liter, multiply by 0.0259.
a
National Health and Nutrition Examination Survey 2011-2012.
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